These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 581694)

  • 1. [Cholangiographic agents in chronic liver diseases: Can toxic liver cell damages be caused by jodoxamid?].
    Ordnung W; Müting D
    Med Klin; 1979 Feb; 74(5):149-53. PubMed ID: 581694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral gallbladder contrast agents in liver damage].
    Ordnung W; Müting D
    Med Klin; 1980 Aug; 75(17):618-20. PubMed ID: 7412711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of iodipamide and lodoxamate using direct and drip infusion intravenous cholangiography.
    Moss AA
    AJR Am J Roentgenol; 1977 Jun; 128(6):931-3. PubMed ID: 414557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time].
    Barner L; Kurzen S
    Med Welt; 1977 Apr; 28(17):817-9. PubMed ID: 577589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with infusion cholegraphy using iotroxamide (Biliscopin ) (author's transl)].
    Stillger E; Persigehl M; Frik W
    Rontgenblatter; 1977 Aug; 30(8):414-20. PubMed ID: 897523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of ioglycamate, a new intravenous cholangiographic medium.
    Masterson JB
    J Ir Med Assoc; 1973 Aug; 66(16):442-4. PubMed ID: 4732631
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast medium tolerance in computed tomography.
    Tschakert H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():156-61. PubMed ID: 6139072
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholangiographic excretion studies: a comparison of iodipamide and iodoxamate in the dog.
    Evill CA; Benness GT
    Invest Radiol; 1976 SEP-OCT; 11(5):459-63. PubMed ID: 989759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New contrast media for angiography (Telebrix, Hexabrix) (author's transl)].
    Bohutová J; Kolár J; Karmazin V; Stupáková Z
    Cas Lek Cesk; 1981; 120(50):1527-30. PubMed ID: 7326714
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast media in abdominal computed tomography. A double blind clinical trial comparing a non-ionic (iohexol) and an ionic (metrizoate) contrast medium.
    Skalpe IO; Ostensen HM
    Eur J Radiol; 1984 Feb; 4(1):74-5. PubMed ID: 6373261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The positive cholangiogram as a quality criterion for a cholangiographic agent (double-blind comparison between iodoxamate and iotroxate].
    Taenzer V; Rehrmann B; Wolf R; Zöllner G
    Rontgenpraxis; 1982 Feb; 35(2):43-6. PubMed ID: 6896099
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombosis following phlebography with high-osmolar and low-osmolar contrast media.
    Eliasen B; Hørup A; Jensen AR
    Eur J Radiol; 1983 May; 3(2):97-8. PubMed ID: 6347689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymuria after administration of water-soluble X-ray contrast media.
    Hartmann HG
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():30-6. PubMed ID: 6139077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].
    Keiner F
    Med Klin; 1976 Oct; 71(44):1885-90. PubMed ID: 1036604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiographic effect of BC-17, a contrast medium for cholangiography, and evaluation of its reliability in radiographic interpretation].
    Oto M; Tsuchiya Y; Saisho H; Momose M; Kumagai T
    Nihon Rinsho; 1975 Apr; 33(4):1750-60. PubMed ID: 1173450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of intravenous cholangio-cholecystography with a meglumine salt of iodoxamic acid with research on fibrinolysis].
    Macchi C; Fiore D; Miotto D; Cella G; Bidoli F
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():549-50. PubMed ID: 1243925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepato-bilary scintigraphy with iodoxamic acid and I-131 rose bengal].
    Ugolotti G
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():51. PubMed ID: 1243923
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased pain reactions as hang-over phenomena after intra-arterial injections of contrast media in rats.
    Hagen B; Siefert HM; Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():57-61. PubMed ID: 6139081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.